Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis

被引：0

作者：

Qu, Chen ^{[1
]}

Zheng, Dandan ^{[1
]}

Li, Sai ^{[2
]}

Lidofsky, Anna ^{[3
]}

Jiang, Yuchuan ^{[1
]}

He, Lu ^{[1
]}

Yuan, Hui ^{[1
]}

Chen, Xijun ^{[1
]}

Hu, Qiaoting ^{[4
]}

Luo, Xiaojun ^{[4
]}

Zhou, Yuchen ^{[1
]}

Lin, Wenyu ^{[3
]}

Chung, Raymond T. ^{[3
]}

Hong, Jian ^{[1
,3
]}

机构：

[1] Southern Med Univ, Dept Abdominal Surg, Ctr Canc, Guangzhou, Guangdong, Peoples R China

[2] Southern Med Univ, Dept Pharm, Ctr Canc, Guangzhou, Guangdong, Peoples R China

[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA USA

[4] Southern Med Univ, Dept Expt Res, Ctr Canc, Guangzhou, Guangdong, Peoples R China

来源：

HEPATOLOGY | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

240

引用

页码：136A / 137A

页数：2

共 50 条

[1] Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis
Qu, Chen
Zheng, Dandan
Li, Sai
Liu, Yingjun
Lidofsky, Anna
Holmes, Jacinta A.
Chen, Jianning
He, Lu
Wei, Lan
Liao, Yadi
Yuan, Hui
Jin, Qimeng
Lin, Zelong
Hu, Qiaoting
Jiang, Yuchuan
Tu, Mengxian
Chen, Xijun
Li, Weiming
Lin, Wenyu
Fuchs, Bryan C.
Chung, Raymond T.
Hong, Jian
HEPATOLOGY, 2018, 68 (03) : 1125 - 1139
[2] The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases
Zhao, Yaping
Liu, Rongrong
Li, Miaomiao
Liu, Pengfei
HELIYON, 2022, 8 (12)
[3] Getting Syk: spleen tyrosine kinase as a therapeutic target
Geahlen, Robert L.
TRENDS IN PHARMACOLOGICAL SCIENCES, 2014, 35 (08) : 414 - 422
[4] Spleen Tyrosine Kinase (SYK) Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
Buchner, Maike
Fuchs, Simon
Prinz, Gabriele
Pfeifer, Dietmar
Bartholome, Kilian
Chevalier, Nina
Vallat, Laurent
Timmer, Jens
Gribben, John G.
Jumaa, Hassan
Veelken, Hendrik
Dierks, Christine
Zirlik, Katja
BLOOD, 2008, 112 (11) : 203 - 203
[5] SPLEEN TYROSINE KINASE (SYK) IS A NOVEL THERAPEUTIC TARGET FOR INTRAHEPATIC CHOLANGIOCARCINOMA
Yuan, Hui
Lin, Zelong
Liu, Yingjun
Weng, Xie
Zhou, Yuchen
Tu, Mengxian
Zheng, Dandan
Li, Jinying
He, Lu
Qu, Chen
Wu, Ziqing
Hong, Jian
HEPATOLOGY, 2019, 70 : 559A - 560A
[6] Inhibition of the B cell associated tyrosine kinase SYK as a potential therapeutic target in aggressive lymphomas.
Bertoni, F
Ridaidi, A
Sasso, A
Uccella, S
Martin, V
Napoli, S
Pruneri, G
Zucca, E
Capella, C
Catapano, CV
Tibiletti, MG
Cavalli, F
BLOOD, 2005, 106 (11) : 424A - 424A
[7] Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis
Torres, Sandra
Ortiz, Cristina
Bachtler, Nadine
Gu, Wenyi
Gruenewald, Leon D.
Kraus, Nico
Schierwagen, Robert
Hieber, Christoph
Meier, Caroline
Tyc, Olaf
Brol, Maximilian Joseph
Uschner, Frank Erhard
Nijmeijer, Bart
Welsch, Christoph
Berres, Marie-Luise
Garcia-Ruiz, Carmen
Fernandez-Checa, Jose Carlos
Trautwein, Christian
Vogl, Thomas J.
Zeuzem, Stefan
Trebicka, Jonel
Klein, Sabine
HEPATOLOGY, 2023, 77 (04) : 1228 - 1240
[8] Prohibitin: a potential therapeutic target in tyrosine kinase signaling
Ande, Sudharsana Rao
Xu, Yang Xin Zi
Mishra, Suresh
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2017, 2
[9] Prohibitin: a potential therapeutic target in tyrosine kinase signaling
Sudharsana Rao Ande
Yang Xin Zi Xu
Suresh Mishra
Signal Transduction and Targeted Therapy, 2
[10] The Syk kinase as a therapeutic target in leukemia and lymphoma
Efremov, Dimitar G.
Laurenti, Luca
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (05) : 623 - 636

← 1 2 3 4 5 →